Treatment of Helicobacter pylori

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 7, Issue 3

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

222

HTML

2359

Figures (1-1)

357

Tables (1-4)

263

Sum=3201

Jun 15, 2001 (publication date) through Feb 21, 2025

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Gastroenterol. Jun 15, 2001; 7(3): 303-307
Published online Jun 15, 2001. doi: 10.3748/wjg.v7.i3.303

Table 3 Quadruple therapy

Therapy	Omeprazole
	Colloidal bismuth subcitrate
	Tetracycline
	Metronidazole
Dosing	o.d.
	120 mg q.d.s.
	500 mg q.d.s.
	400 mg q.d.s.
Duration	One week
Side effects	Common: nausea, diarrhoea, taste disturbances
H. pylori eradication	＞ 75% in MRS
H. pylori eradication	＞ 90% in MSS

o.d.: Once daily; q.d.s.: Four times daily; MRS: Metronidazole-resistant strains of H. pylori; MSS: Metronidazole-sensitive strains of H. pylori

Citation: Harris A. Treatment of Helicobacter pylori. World J Gastroenterol 2001; 7(3): 303-307
URL: https://www.wjgnet.com/1007-9327/full/v7/i3/303.htm
DOI: https://dx.doi.org/10.3748/wjg.v7.i3.303